Assessment and validation of emulgel-based salicylic acid formulation development for drug release and optimisation by statistical design Online publication date: Tue, 31-Oct-2023
by Ch. Taraka Ramarao; Ishwarya Bammidi; Manasa Banala; Kundansai Balaga; Pavani Cheekati; Yamani Busa
International Journal of Computational Biology and Drug Design (IJCBDD), Vol. 15, No. 6, 2023
Abstract: Salicylic acid is used topically to treat a variety of skin problems, such as acne, dandruff, psoriasis, seborrheic dermatitis, calluses, corns and warts. The effects of Methocel K100 LV, Cetostearyl alcohol and Span80 independent variables on the drug release of emulgel utilised to create design expert software. The formulations of three underwent testing for physical characteristics, spreadability, washability, skin irritability, agar plate diffusion and drug release. When comparing S7 to the commercial product (Salicylix SF12), a considerable contribution was discovered. The design expert was utilised to determine the effects of the three aspects individually and collectively. There was a significant as indicated by the analysis of variance results (p < 0.05). The formulation variables need to be controlled to produce an emulgel with the necessary performance qualities. The predictability and validity of the model were demonstrated when the experimental results matched the predicted values.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Computational Biology and Drug Design (IJCBDD):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com